Australia's most trusted
source of pharma news
Friday, 26 June 2026
Posted 26 June 2026 AM
Australian radiopharma AdvanCell is setting up a global headquarters and future manufacturing facility in the US.
A leased 128,000-square-foot facility at Andover, in Greater Boston, will become AdvanCell’s corporate HQ and US flagship manufacturing centre, supporting long-term growth and commercialisation, as the company aims to evolve into a US-based radiopharma with integrated operations across North America and Australia.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.